Search for Clinical Trial Results
Hypothyroidism - 36 Studies Found
Status | Study |
Completed |
Study Name: Phase 4 Study in Secondary Hypothyroidism: Body Weight Adapted Thyroxin Treatment and Triiodothyronine Supplementation Condition:
|
Completed |
Study Name: Growth Hormone and GnRH Agonist in Adolescents With Acquired Hypothyroidism Condition: Hypothyroidism Date: 2005-09-13 Interventions:
|
Completed |
Study Name: Central Hypothyroidism, a Novel Laboratory Measurement Condition: Central Hypothyroidism Date: 2011-01-19 Interventions: Drug: Eltroxin Eltroxin dosage titration according to free T4 measurement every 3 months |
Completed |
Study Name: Observational Study With Prospective and/or Retrospective Follow-up, Without Modifying Patient Treatment and Follow-up Practices for the Initial Treatment of Hypothyroidism in France Condition: Hypothyroidism Date: 2010-08-18 |
Recruiting |
Study Name: Mean Percentage of Levothyroxine Dosage Increase in Patients With Hypothyroidism Started on Enteral Feeding Condition: Hypothyroidism Date: 2015-09-14 Interventions: Drug: Levothyroxine Administer Levothyroxine Other N |
Completed |
Study Name: Neurocognitive and Metabolic Effects of Mild Hypothyroidism Condition: Hypothyroidism Date: 2007-11-28 Interventions: Drug: L-thyroxine (L-T4) L-thyroxine at doses appropriate to attain target TSH levels for the different |
Completed |
Study Name: Maternal Hypothyroidism in Pregnancy Condition: Hypothyroidism Date: 2009-01-06 |
Terminated |
Study Name: Lipids Profile in Subclinical Hypothyroidism Condition: Subclinical Hypothyroidism Date: 2009-08-18 Interventions: Procedure: laboratory analysis laboratory analysis |
Recruiting |
Study Name: The Prevalence of Sub Clinical Hypothyroidism During Early Pregnancy in Pakistan Condition: Subclinical Hypothyroidism Date: 2017-01-26 |
Recruiting |
Study Name: Iodinated Contrast Agents and Risk of Hypothyroidism in Young Children in the United States Condition: Hypothyroidism Date: 2016-10-11 Interventions: Drug: Iodinated contrast agents Use of iodine contrast agents and doses following the decision of the tr |